- Investing Ideas
- /
- New Zealand Biotech Stocks
New Zealand Biotech Stocks
Results
4
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
4 companies
AFT Pharmaceuticals
Market Cap: NZ$275.8m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.80
7D
7.3%
1Y
-12.5%
Pacific Edge
Market Cap: NZ$177.9m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.18
7D
0%
1Y
18.5%
BLIS Technologies
Market Cap: NZ$21.7m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.017
7D
0%
1Y
41.7%
Rua Bioscience
Market Cap: NZ$9.3m
Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.037
7D
-15.9%
1Y
-14.0%